Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2010
03/18/2010WO2009120339A3 Vectors for delivering disease neutralizing agents
03/18/2010WO2009100024A3 METHODS OF MODULATING THE ORGANIC SOLUTE AND STEROID TRANSPORTER (OSTα-OSTβ) ACTIVITY AND TREATING ASSOCIATED CONDITIONS
03/18/2010WO2009090650A3 Vaccine for alzheimer's disease
03/18/2010WO2009009045A3 Escape libraries of target polypeptides
03/18/2010US20100071079 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
03/18/2010US20100071078 Rspondins as modulators of angiogenesis and vasculogenesis
03/18/2010US20100068263 Method and Compositions for Stimulation of an Immune Response to TRP2 using a Xenogeneic TRP2 Antigen
03/18/2010US20100068262 Method and Compositions for Stimulation of an Immune Response to PSMA using a Xenogeneic PSMA Antigen
03/18/2010US20100068261 Methods and compositions for the production of monoclonal antibodies
03/18/2010US20100068258 Prophylactic tuberculosis vaccine
03/18/2010US20100068255 liposomes comprising humanized Fab fragment of monoclonal antibody that binds cell surface markers, amphipathic vesicle-forming lipid and polyethylene glycol derivatized lipid, capable of inhibiting growth and proliferation of target cells; HER growth factor receptors
03/18/2010US20100068244 Stabilized biodegradable neurotoxin implants
03/18/2010US20100068232 Methods for treating skin lines and wrinkles and improving skin quality
03/18/2010US20100068231 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent
03/18/2010US20100068230 also comprises nucleic acid molecule (modified by contact with a psoralen activated by ultraviolet radiation) encoding non-Listerial antigen; immunogens; antigen presenting cells
03/18/2010US20100068229 Recombinant antigens of human cytomegalovirus (hcmv)
03/18/2010US20100068228 Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions
03/18/2010US20100068227 Composition Useful as a Vaccine
03/18/2010US20100068226 Polynucleotides and Uses Thereof
03/18/2010US20100068225 Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof
03/18/2010US20100068224 Method for Producing Viral Vaccine and Therapeutic Peptide Antigens
03/18/2010US20100068223 Storage of Influenza Vaccines Without Refrigeration
03/18/2010US20100068222 Hapten-carrier conjugates for use in drug abuse therapy and methods for preparation of same
03/18/2010US20100068220 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
03/18/2010US20100068219 Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide
03/18/2010US20100068218 Optimized Multi-Epitope Constructs and Uses Thereof
03/18/2010US20100068217 Epitope-transplant scaffolds and their use
03/18/2010US20100068216 Method and Compositions for Stimulation of an Immune Response to gp100 using a Xenogeneic gp100 Antigen
03/18/2010US20100068215 Use of GDF traps to increase red blood cell levels
03/18/2010US20100068214 Identification of Candidate Vaccine Antigens from Dichelobacter Nodosus
03/18/2010US20100068213 Selected colostrum for treatment of intestinal barrier function disorders
03/18/2010US20100068212 Targeting pathogenic monocytes
03/18/2010US20100068211 Use of antiresorptive compounds to prevent ionizing radiation-induced activation of osteoclasts and resulting bone loss
03/18/2010US20100068210 Compositions and methods for the prevention of oxidative degradation of proteins
03/18/2010US20100068209 Antibacterial compositions for drug administration
03/18/2010US20100068208 Degranulation inhibitor
03/18/2010US20100068207 DDR2 in Cancer Diagnosis, Detection and Treatment
03/18/2010US20100068206 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
03/18/2010US20100068205 Methionine Sulfoxide Antibodies
03/18/2010US20100068204 4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
03/18/2010US20100068203 17-Oxymacbecin Derivatives and Their Use in the Treatment of Cancer and/or B-Cell Malignancies
03/18/2010US20100068202 Method of treating hemolytic disease
03/18/2010US20100068201 Compositions and methods for the systemic treatment of arthritis
03/18/2010US20100068200 Methods and Compositions for Inhibiting Atherosclerosis and Vascular Inflammation
03/18/2010US20100068199 Pcsk9 antagonists
03/18/2010US20100068198 Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseases
03/18/2010US20100068197 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
03/18/2010US20100068181 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/18/2010US20100068180 Novel methods for modulating inflammatory and/or immune responses
03/18/2010US20100068179 Phosphohalohydrins, Process For The Production Thereof And Use Thereof
03/18/2010US20100068178 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068175 Methods of using Fc-Cytokine fusion proteins
03/18/2010US20100068174 Combination with bis (thiohydrazide amides) for treating cancer
03/18/2010US20100068151 Multimodality molecular imaging with therapeutic conjugates
03/18/2010US20100068145 Bispecific fusion protein having therapeutic and diagnostic potential
03/18/2010US20100068142 Melanoma repopulating cells
03/18/2010US20100068137 Dock-and-Lock (DNL) Vaccines for Cancer Therapy
03/18/2010US20100068136 Anti-CD19 Antibodies
03/18/2010US20100068135 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
03/18/2010CA2737056A1 Targeting pathogenic monocytes
03/18/2010CA2736851A1 System and method for producing t cells
03/18/2010CA2736829A1 Pd-1 specific antibodies and uses thereof
03/18/2010CA2736816A1 Pd-1 specific antibodies and uses thereof
03/18/2010CA2736543A1 Non-typhoidal salmonella vaccines
03/18/2010CA2736349A1 Pcsk9 antagonists
03/18/2010CA2734694A1 Methods for inhibiting ocular angiogenesis
03/17/2010EP2163896A1 Method for detection or treatment of graft versus host disease
03/17/2010EP2163640A1 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
03/17/2010EP2163628A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
03/17/2010EP2163625A1 IL-17 and IL-17R homologous polypeptides and therapeutic uses thereof
03/17/2010EP2163564A1 Cancerous disease modifying antibodies
03/17/2010EP2163562A2 IL-1beta binding antibodies and fragments thereof
03/17/2010EP2163561A1 NOGO receptor-mediated blockade of axonal growth
03/17/2010EP2163260A2 Chimpanzee adenovirus vaccine carriers
03/17/2010EP2163258A1 Preventive/remedy for cancer
03/17/2010EP2163257A1 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
03/17/2010EP2163256A1 Specific binding proteins and uses thereof
03/17/2010EP2163255A1 Tuberculosis vaccines comprising antigens expressed during the latent infection phase
03/17/2010EP2162471A1 Compositions and methods for treating pancreatic tumors
03/17/2010EP2162470A2 C3b antibodies and methods for the prevention and treatment of complement- associated disorders
03/17/2010EP2162460A2 Vaccines against chlamydia infection
03/17/2010EP2162156A2 Immunocytokines for cancer treatment in combination with chemotherapeutic agents
03/17/2010EP2162151A1 A live attenuated antigenically marked classical swine fever vaccine
03/17/2010EP2162150A1 Vaccine against clostridium perfringens
03/17/2010EP2162149A1 Vaccine for the prevention of breast cancer relapse
03/17/2010EP2162148A2 System and method for sparql-query processing using parametrized-sparql-query in dbms-based systems
03/17/2010EP2162133A1 Methods for reducing allergies caused by environmental allergens
03/17/2010EP1929047B1 Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity
03/17/2010EP1556493B1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof
03/17/2010EP1506225B2 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
03/17/2010EP1490098B1 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
03/17/2010EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use
03/17/2010EP1027439B1 Multivalent antigen-binding proteins
03/17/2010EP0833923B2 Immunogenic construct, process for its preparation and use as a vaccine
03/17/2010CN101675158A Cancerous disease modifying antibodies
03/17/2010CN101675079A Binding members for ige molecules
03/17/2010CN101675075A Recombinant anti-epidermal growth factor receptor antibody compositions
03/17/2010CN101675074A antibodies and methods for making and using them
03/17/2010CN101675068A Novel method and compositions
1 ... 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 ... 1823